JL
James E. Levine
Chief Financial Officer

James E. Levine insider trades: Cardiff Oncology (CRDF) stock purchases

Chief Financial Officer, Cardiff Oncology Last trade Dec 18, 2024 27 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2010
4
Companies
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where James reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 18, 2024CRDF↑ Buy$37K
Sep 16, 2022CRDF↑ Buy$47K
Sep 10, 2021CRDF↑ Buy$194K
Nov 10, 2020CDTX↑ Buy$101K
Sep 24, 2019CDTX↑ Buy$57K
May 15, 2012VRNM↑ Buy$18K
Aug 25, 2011VRNM↑ Buy$80K
Aug 12, 2011VRNM↑ Buy$42K
Aug 16, 2010VRNM↑ Buy$125K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CRDF insiders

Open-market trades in the last 12 months

About James E. Levine's insider trades

James E. Levine is Chief Financial Officer at Cardiff Oncology (CRDF). Since Aug 16, 2010, James has reported 9 open-market purchases worth $701K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (16 filings), option exercises (2 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CRDF insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.